Sanofi
SNY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001121404
No open-market purchases or sales by Sanofi insiders were filed in the last 90 days; 718 institutions reported holding it in 13F filings for Q2 2026, worth $8.08B in total; Maverick Capital is the only superinvestor holding it.
Other share classesSNYNF
13F holders, Q2 2022
Institutional positions in Sanofi as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 657
- +43 vs. Q1 2022
- Shares held
- 258.3M
- +10.0M (+4.0%) vs. Q1 2022
- Total value
- $12.9B
- +$179.9M (+1.4%) vs. Q1 2022
- New holders
- 87
- 245 more added
- Sold out
- 44
- 185 more reduced
10 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 718 | $8.08B |
| Q1 2026 | 746 | $10.1B |
| Q4 2025 | 757 | $10.8B |
| Q3 2025 | 711 | $11.2B |
| Q2 2025 | 730 | $11.8B |
| Q1 2025 | 774 | $14.4B |
| Q4 2024 | 732 | $12.8B |
| Q3 2024 | 758 | $16.3B |
| Q2 2024 | 731 | $13.2B |
| Q1 2024 | 711 | $12.5B |
| Q4 2023 | 709 | $12.3B |
| Q3 2023 | 697 | $13.5B |
| Q2 2023 | 673 | $13.7B |
| Q1 2023 | 679 | $14.5B |
| Q4 2022 | 644 | $12.7B |
| Q3 2022 | 588 | $9.68B |
| Q2 2022 | 657 | $12.9B |
| Q1 2022 | 624 | $12.9B |
| Q4 2021 | 626 | $12.2B |
| Q3 2021 | 580 | $11.4B |
| Q2 2021 | 589 | $10.7B |
| Q1 2021 | 575 | $9.77B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Sanofi; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Teachers Retirement System of the State of Kentucky | – | – | – | – | Not filed |
| Holloway Wealth Management, LLC | – | – | – | – | Not filed |
| Palladium Partners LLC | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Golden State Equity Partners | – | – | – | – | Not filed |
| American National Insurance Co | – | – | – | – | Not filed |
| Dixon Hughes Goodman Wealth Advisors LLC | – | – | – | – | Not filed |
| Kings Point Capital Management | – | – | – | – | Not filed |
| Ritter Daniher Financial Advisory, LLC | – | – | – | – | Not filed |